Literature DB >> 168339

Prenatal diagnosis and fetal pathology of I-cell disease (mucolipidosis type II).

P Aula, J Rapola, S Autio, K Raivio, O Karjalainen.   

Abstract

Increased activity of several lysosomal hydrolases was demonstrated in amniotic fluid from a fifteenth week pregnancy in which the fetus had I-cell disease. Cultured cells from amniotic fluid had a decreased activity of the same enzymes. The diagnosis of I-cell disease was later confirmed by enzyme assays in cell cultures of fetal skin and by morphologic studies of several tissues from the aborted fetus. Electron microscopic studies of the fetal tissues and cultured fibroblasts had large numbers of typical inclusions of I-cell disease, thus substantiating the diagnosis and intrauterine manifestation of the disease. The results indicate that prenatal diagnosis of I-cell disease is possible with enzyme assays of amniotic fluid and in cultures of fetal cells from the fluid. Enzyme studies of amniotic fluid can provide a preliminary diagnosis within a few hours, but it is suggested that the definitive diagnosis should be based on assays in cultured cells from amniotic fluid.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168339     DOI: 10.1016/s0022-3476(75)80583-x

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  I-cell disease.

Authors:  P J Milla
Journal:  Arch Dis Child       Date:  1978-06       Impact factor: 3.791

2.  Prenatal diagnosis of I-cell disease by measuring altered alpha-mannosidase activity in amniotic fluid.

Authors:  M Owada; O Nishiya; T Sakiyama; T Kitagawa
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

3.  Vacuolization of mucolipidosis type II mouse exocrine gland cells represents accumulation of autolysosomes.

Authors:  Marielle Boonen; Eline van Meel; Viola Oorschot; Judith Klumperman; Stuart Kornfeld
Journal:  Mol Biol Cell       Date:  2011-02-16       Impact factor: 4.138

4.  I-cell disease.

Authors:  Z M Patel; L M Ambani
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

5.  Prenatal diagnosis of mucolipidosis II (I-cell disease).

Authors:  J Gehler; M Cantz; M Stoeckenius; J Spranger
Journal:  Eur J Pediatr       Date:  1976-06-08       Impact factor: 3.183

6.  Altered chondrocyte differentiation and extracellular matrix homeostasis in a zebrafish model for mucolipidosis II.

Authors:  Heather Flanagan-Steet; Christina Sias; Richard Steet
Journal:  Am J Pathol       Date:  2009-10-15       Impact factor: 4.307

7.  I-cell disease. A further report on its pathology.

Authors:  J J Martin; J G Leroy; M van Eygen; C Ceuterick
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

8.  Morphological study of skin biopsy specimens: a contribution to the diagnosis of metabolic disorders with involvement of the nervous system.

Authors:  J J Martin; C Ceuterick
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-03       Impact factor: 10.154

9.  Placental pathology in an unsuspected case of mucolipidosis type II with secondary hyperparathyroidism in a premature infant.

Authors:  Parith Wongkittichote; Garland Michael Upchurch; Louis P Dehner; Timothy Wood; Jorge L Granadillo
Journal:  Mol Genet Metab Rep       Date:  2021-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.